Key facts
- This page summarizes M. Kathleen Behrens's Form 4 filing for MIMEDX GROUP, INC. (MDXG).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 23 Jun 2025, 18:42.
M. Kathleen Behrens - 18 Jun 2025 Form 4 Insider Report for MIMEDX GROUP, INC. (MDXG)
- Reporting relationship
- Director
- Issuer ticker
- MDXG
- Reported as of
- 18 Jun 2025
- Net transaction value
- +$185,100
- SEC form
- 4
- Accepted by SEC
- 23 Jun 2025, 18:42:57 UTC
- Prior SEC filing
- 02 Apr 2025
- Next SEC filing
- 02 Jul 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ William F. Hulse as attorney-in-fact M. Kathleen Behrens Wilsey
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
M. Kathleen Behrens filed Form 4 for MIMEDX GROUP, INC. (MDXG) on 23 Jun 2025.
Change
- Previous filing in this sequence was filed on 02 Apr 2025.
- Current net transaction value: +$185,100.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001211701
Primary reporting owner
BEHRENS M KATHLEEN
- Relationship
- Director
- Address
- 1775 WEST OAK COMMONS COURT, MARIETTA
- Signature
- /s/ William F. Hulse as attorney-in-fact M. Kathleen Behrens Wilsey
- Signature date
- 23 Jun 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MDXG
transaction
Common Stock
Award
- Transaction value
- $185,100
- Shares
- +28,609
- Change %
- +16%
- Price
- $6.47
- Shares after
- 212,771
- Date
- 18 Jun 2025
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders